MedTrace Logo

Arterial Wave Energy Flux and Multidimensional Recovery in Patients With Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

NCT07522203 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this observational study is to learn if advanced heart pressure wave analysis (called WIA and REPA) can help track and predict clinical improvement in adults (aged 18-85) with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) who are undergoing Balloon Pulmonary Angioplasty (BPA).

The main questions it aims to answer are:

Do changes in these advanced heart pressure wave patterns relate to improvements in a patient's walking distance, heart function, and overall quality of life after BPA treatment?

Are these new measurements more effective than standard heart pressure tests at showing how much a patient has truly improved?

Participants will:

Undergo standard Balloon Pulmonary Angioplasty (BPA) sessions as part of their regular medical care for CTEPH.

Have their heart pressure waves recorded through a catheter during the routine BPA procedure (this does not require any extra surgical steps).

Complete walking tests (6-minute walk test), blood tests, and heart ultrasounds (echocardiography) before starting the treatment and after it is completed.

Fill out short surveys regarding their daily physical activity and quality of life.

Conditions

  • CTEPH
  • Pulmonary Hypertension (PH)

Interventions

PROCEDURE

Balloon Pulmonary Angioplasty

Balloon Pulmonary Angioplasty as per procedural standards

Sponsors & Collaborators

  • Istanbul Mehmet Akif Ersoy Educational and Training Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2028-04-01
Completion
2028-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07522203 on ClinicalTrials.gov